BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, featuring promising progress across various health care and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, additional responsible alternative for therapeutic use, sign